Leflunomid Al

Leflunomide, the active ingredient in Leflunomid Al, is an immunomodulatory disease‑modifying antirheumatic drug (DMARD) presented as an oral tablet for oral use. It is indicated for the treatment of rheumatoid arthritis and psoriatic arthritis in adult patients who require long‑term disease control, and improves functional ability and quality of life.

GNH USA supplies Leflunomid Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Leflunomide is used to manage autoimmune inflammatory disorders affecting the joints. - Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Psoriatic arthritis: decreases skin and joint symptoms and limits disease progression. - Active inflammatory arthritis: helps control disease activity when other DMARDs are insufficient.

Leflunomid Al may cause a range of adverse reactions.

Common Side Effects: - Diarrhea: loose stools and abdominal discomfort. - Nausea: feeling of sickness, sometimes with vomiting. - Headache: mild to moderate head pain. - Elevated blood pressure: increase in systolic/diastolic readings.

Serious or Rare Side Effects: - Hepatotoxicity: significant liver enzyme elevation or liver injury. - Severe infections: increased susceptibility to bacterial, viral or fungal infections. - Bone marrow suppression: low blood counts leading to anemia or neutropenia.

Before initiating therapy, several safety considerations are required. - Liver monitoring: perform baseline and periodic liver function tests. - Blood pressure: monitor regularly, especially in patients with hypertension. - Pregnancy avoidance: contraindicated in pregnancy (Category X) and women of child‑bearing potential must use effective contraception. - Renal impairment: adjust use cautiously in patients with reduced renal function. - Live vaccines: avoid administration while on therapy due to immunosuppression. - Store at ambient temperature: keep in the original pack, protect from moisture.

Leflunomid Al can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Methotrexate: combined use can increase hepatotoxicity. - Warfarin: leflunomide may potentiate anticoagulant effect. - Live vaccines: risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - NSAIDs: may raise blood pressure. - Statins: possible increased risk of myopathy.